Trials / Completed
CompletedNCT00976690
Comparison Azathioprine to Mesalazine for the Prevention of Postoperative Recurrence in the Crohn Disease
A Multicentre Randomized Open Study Comparing Azathioprine to Mesalazine for the Prevention of Postoperative Recurrence in the Crohn Disease
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 83 (actual)
- Sponsor
- Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To show the superiority of Azathioprine comparing Mesalazine in the prevention of postoperative recurrence in Crohn's Disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Azathioprine OR Mesalazine | Azathioprine : 2mg/kg/day Mesalazine : 4g/day |
Timeline
- Start date
- 2002-10-01
- Primary completion
- 2010-10-01
- Completion
- 2010-12-01
- First posted
- 2009-09-14
- Last updated
- 2011-08-31
Locations
14 sites across 1 country: France
Source: ClinicalTrials.gov record NCT00976690. Inclusion in this directory is not an endorsement.